Making innate sense of mRNA vaccine adjuvanticity

Nat Immunol. 2022 Apr;23(4):474-476. doi: 10.1038/s41590-022-01168-4.

Kouji Kobiyama^{1

2

3}, Ken J Ishii^{4

5

6}

¹ Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
² International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
³ Center for Vaccine Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
⁴ Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. kenishii@ims.u-tokyo.ac.jp.
⁵ International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. kenishii@ims.u-tokyo.ac.jp.
⁶ Center for Vaccine Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan. kenishii@ims.u-tokyo.ac.jp.

No abstract available

Publication types